Diagnostic Approach to Thrombocytopenia

Initial Evaluation

The American Society of Hematology recommends confirming true thrombocytopenia by examining the peripheral blood smear to exclude pseudothrombocytopenia due to platelet clumping in EDTA tubes, which occurs in about 0.1% of adults 2
A complete blood count with differential should be performed to assess for other cytopenias that may suggest specific diagnoses, as recommended by the American College of Physicians 1

The American College of Physicians suggests that bleeding symptoms, medication history, recent vaccinations, transfusion history, family history of thrombocytopenia, risk factors for HIV infection, comorbid conditions, and recent trauma or surgeries should be assessed, as these factors can contribute to thrombocytopenia 2
The Centers for Disease Control and Prevention recommends assessing vaccination history, particularly for vaccines that may induce immune thrombocytopenia and thrombosis, such as the COVID-19 vaccine 3

The American Society of Hematology recommends assessing for bleeding signs, such as petechiae, purpura, ecchymosis, and retinal hemorrhages, as well as evaluating for hepatosplenomegaly, lymphadenopathy, signs of infection, and evidence of autoimmune disease 2
The American College of Cardiology suggests evaluating for signs of thrombosis, which may indicate heparin-induced thrombocytopenia or antiphospholipid syndrome 4

The American Society of Hematology recommends performing a complete blood count with differential and peripheral blood smear, as well as prothrombin time and activated partial thromboplastin time, to assess for coagulopathy 1
The American College of Physicians suggests measuring D-dimer and fibrinogen assay to assess for disseminated intravascular coagulation (DIC) 1
The British Medical Journal recommends performing HIV testing for patients with risk factors, as well as bone marrow examination for patients with persistent thrombocytopenia or abnormal cells on peripheral smear 2, 5

For suspected heparin-induced thrombocytopenia (HIT), the American Society of Hematology recommends applying the 4T score, which assesses thrombocytopenia severity, timing of onset, thrombosis, and other potential causes of thrombocytopenia 4, 6
For suspected immune thrombocytopenia (ITP), the American College of Physicians recommends confirming isolated thrombocytopenia, excluding other causes, and considering bone marrow examination for patients with persistent thrombocytopenia or atypical features 2, 5
For suspected vaccine-induced immune thrombocytopenia and thrombosis (VITT), the British Medical Journal recommends assessing vaccination history, performing initial tests, and measuring D-dimer and coagulation screen, including Clauss fibrinogen assay 3

For ITP, the American Society of Hematology recommends first-line therapy with corticosteroids, IVIG, or anti-Rh(D), and considering romiplostim or splenectomy for insufficient response 2
For VITT, the British Medical Journal recommends administering intravenous immunoglobulin and using non-heparin based anticoagulants for confirmed thrombosis 3
For HIT, the American College of Cardiology recommends discontinuing all heparin products and using alternative anticoagulants, such as direct oral anticoagulants, fondaparinux, or danaparoid sodium 4, 6

The American Society of Hematology recommends avoiding the assumption that thrombocytopenia is always due to a single cause, and considering multiple pathologies that may coexist 1
The American College of Physicians suggests avoiding delaying bone marrow examination when clinically indicated, especially with high suspicion for malignancy 1
The British Medical Journal recommends avoiding overlooking drug-induced causes, particularly heparin, quinidine, and sulfonamides 2